IMCC

distress 1/10 · well-funded / low risk

$0.14+1%today-96% from 52w high

imcannabis.com44 employeesFounded 2008Vancouver, BCDrug Manufacturers - Specialty & Generic

Revenue

pre-revenue

Liquidity

$3M

Runway

—

Shares 1y

Price & events

-89.9% over 6M

CatalystRating changeDilutionFinancingdashed = today

+1.0%

-3.3%

-16.3%

-54.2%

-89.8%

-95.5%

-94.7%

-100.0%

All

Overview

Market Cap: $809.36K
Enterprise Value: $590.36K
Volume: 12.62K
52 Week Range: $0.13 – $3.42
Total Shares: 5.89M
Float Shares: 4.06M
Short %: 4.61%
% Held by Insiders: 35.15%
% Held by Institutions: 0.46%
RVOL: 0.00x
Beta: 2.04

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 5,894,812 · 0 offerings/1y · 0 PIPEs

2026-06-16EFFECTshelf_effective
2026-06-09F-3shelf_registration
2026-02-11EFFECTshelf_effective
2026-02-05F-3shelf_registration
2025-08-27EFFECTshelf_effective
2025-08-25F-3/Ashelf_registration
2025-08-13F-3shelf_registration

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified